The HIV/AIDS study group, Research Center on Global Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease Universitas Airlangga successfully held a Policy Brief Dialogue with the theme “The Role of Antiretroviral Resistance Examination as an Effort to Control HIV Cases in Indonesia.”

This activity was carried out in a hybrid manner at the Harris Hotel, Gubeng Surabaya, on Wednesday, October 19, 2022. It was attended by a great resource person, Prof. Dr. Nasronudin, dr. Sp.PD., KPTI-FINASIM as the director of Airlangga Hospital, and dr. Ratna Budi Hapsari M.KM as the HIV PIMS Hepatitis PISP work team of the Indonesian Ministry of Health.

This activity was also attended by clinicians, researchers, non-governmental organizations, and policymakers. This activity aims to support the WHO program to end AIDS with a target of 95.95.95, which means 95% of people living with HIV know their HIV status, 95% of people who know their status on treatment, and 95% of people on treatment with suppressed viral loads. In addition, this activity is also to support the Indonesian Ministry of Health’s program named STOP (Educate, Test, Treat, and Maintain). Hopefully, this brief policy dialogue can provide recommendations to complement the achievements of handling HIV/AIDS in Indonesia.